Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors
Clinical trial NCT07275853 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07275853
- Sponsor
- TCRx Therapeutics Co.Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.